Southpoint Capital Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,382,100
Closed -$163M 50
2022
Q1
$163M Buy
2,382,100
+115,286
+5% +$8.21M 3.17% 15
2021
Q4
$179M Buy
2,266,814
+100,372
+5% +$8.4M 3.44% 11
2021
Q3
$171M Buy
2,166,442
+338,070
+18% +$27.2M 3.65% 8
2021
Q2
$144M Buy
1,828,372
+177,966
+11% +$13.6M 2.5% 17
2021
Q1
$124M Buy
1,650,406
+1,388,956
+531% +$102M 2% 23
2020
Q4
$17.2M Buy
+261,450
New +$15.3M 0.3% 46

Other funds holding ENOV

Southpoint Capital Advisors's ENOV Position: Q2 2022 in Review

Southpoint Capital Advisors sold out of Enovis (ENOV) in Q2 2022, closing a stake of 2,382,100 shares — an estimated $163M sold.

Southpoint Capital Advisors first reported a position in ENOV in Q4 2020 and held it in 6 quarters. The position peaked at $179M in Q4 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Southpoint Capital Advisors reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Southpoint Capital Advisors sold 2,382,100 Enovis shares in Q2 2022, an estimated $163M.
  • Southpoint Capital Advisors first reported a position in Enovis in Q4 2020 and held it in 6 quarters.
  • Southpoint Capital Advisors's Enovis position peaked at $179M in Q4 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Southpoint Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.